T0	Disease 77 86	hypoxemia
T1	Disease 91 95	CCHD
T11	Disease 883 892	hypoxemia
T12	Disease 897 901	CCHD
T14	Biomarker 1013 1021	c.380G>C
T16	Disease 1043 1050	hypoxia
T23	Disease 1569 1573	CCHD
T26	Disease 1694 1698	CCHD
T27	Disease 1704 1711	hypoxia
T29	Disease 1834 1838	CCHD
T3	Disease 346 353	hypoxia
#10	AnnotatorNotes T3	D000860
T4	Disease 383 387	CCHD
T5	Chemical 488 494	oxygen
T6	Disease 552 561	hypoxemia
T7	Chemical 595 601	oxygen
T8	Chemical 758 760	Oâ‚‚
T9	Disease 786 793	hypoxia
T2	Gene-Protein 34 38	PHD2
#1	AnnotatorNotes T2	HGNC:1232
T10	Gene-Protein 39 45	HIF-1A
#2	AnnotatorNotes T10	HGNC:4910
T13	GeneFamily 230 234	VEGF
#3	AnnotatorNotes T13	family:1267
T15	Gene-Protein 292 298	HIF-1A
T18	GeneFamily 439 443	VEGF
T20	Gene-Protein 581 584	EPO
T22	GeneFamily 849 853	VEGF
T25	Gene-Protein 936 940	PHD2
T28	Gene-Protein 941 947	HIF-1A
T30	Gene-Protein 858 861	EPO
T31	Gene-Protein 236 239	EPO
#4	AnnotatorNotes T31	HGNC:3415
T32	Disease 1155 1162	hypoxia
T33	Gene-Protein 1334 1340	HIF-1A
T34	Disease 1800 1807	hypoxic
T35	GeneFamily 1498 1502	VEGF
T36	Gene-Protein 1384 1387	EPO
T37	Gene-Protein 1507 1510	EPO
T38	GeneFamily 1375 1379	VEGF
T39	Biomarker 1067 1106	higher collateral vessel formation rate
T40	Gene-Protein 1462 1468	HIF-1A
T41	Gene-Protein 1457 1461	PHD2
T42	Gene-Protein 1741 1747	HIF-1A
T43	Gene-Protein 1736 1740	PHD2
#5	AnnotatorNotes T0	D000860
#6	AnnotatorNotes T1	DOID:1682
T44	Disease 173 180	hypoxic
#7	AnnotatorNotes T44	DOID:1682
T45	Disease 515 522	hypoxic
T46	Disease 697 704	hypoxic
T47	Disease 1533 1540	hypoxia
T48	Disease 1245 1252	hypoxic
T49	Biomarker 1213 1230	c.380G>C mutation
T17	Biomarker 34 53	PHD2/HIF-1A pathway
T50	Collection 77 95	hypoxemia and CCHD
R1	Association Arg1:T17 Arg2:T50	
T51	Collection 515 561	hypoxic response in individuals with hypoxemia
T52	Drug 421 443	Overexpression of VEGF
#8	AnnotatorNotes T52	not found
R2	Response Arg1:T52 Arg2:T51	
T53	Biomarker 831 861	overexpression of VEGF and EPO
T54	Collection 883 901	hypoxemia and CCHD
T56	Biomarker 1306 1323	c.380G>C mutation
T19	Biomarker 1375 1404	VEGF and EPO were upregulated
T57	Biomarker 1412 1429	c.380G>C mutation
T21	Biomarker 1653 1670	c.380G>C mutation
T24	Collection 1694 1711	CCHD from hypoxia
R5	Risk-Reduce Arg1:T21 Arg2:T24	
T58	Drug 193 272	upregulating the adaptive gene (e.g. VEGF, EPO, and several glycolytic enzymes)
#13	AnnotatorNotes T58	not found
T59	Collection 346 387	hypoxia, and improves the outcome of CCHD
R6	Response Arg1:T58 Arg2:T59	
R7	Risk-Reduce Arg1:T14 Arg2:T16	
R8	Risk-Reduce Arg1:T49 Arg2:T48	
T60	Biomarker 1480 1510	Overexpression of VEGF and EPO
T61	Collection 1533 1573	hypoxia and improves the outcome of CCHD
R9	Association Arg1:T60 Arg2:T61	
R3	Prognostic-Good Arg1:T53 Arg2:T54	
